Follow Nuclera at:


Nuclera are on a mission to better human health by increasing accessibility to proteins.

Nuclera’s eProtein Discovery™ system offers rapid access to high-quality, soluble, active proteins at the benchtop, allowing scientists to automate construct screening, inform off-platform protein scale-up and deliver reliable protein in-hand (µg-mg amounts) in less than 48 hours.

Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, facilitating rapid development on protein projects via an automated, high-throughput protein access system.

Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Amadeus contact

Andrea Traversone